What is the current Norovirus Nucleic Acid Test Kit market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Norovirus Nucleic Acid Test Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Norovirus Nucleic Acid Test Kit market?

Increasing demand for diagnostic testing and rising awareness of norovirus infections drive the market.

What are the major challenges facing the Norovirus Nucleic Acid Test Kit market?

Stringent regulatory requirements and competition from alternative diagnostic methods pose challenges.

Which regions are the leaders in the Norovirus Nucleic Acid Test Kit market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Norovirus Nucleic Acid Test Kit market?

Prominent players include Abbott Laboratories, Bio-Rad Laboratories, and Thermo Fisher Scientific.

What future opportunities exist in the Norovirus Nucleic Acid Test Kit market?

Emerging markets and technological advancements in diagnostic testing offer future growth opportunities.

How does technology impact the Norovirus Nucleic Acid Test Kit market?

Advances in molecular diagnostics and point-of-care testing improve market efficiency and accuracy.

What is the regulatory landscape for the Norovirus Nucleic Acid Test Kit market?

Regulatory frameworks vary by region, with FDA and CE markings governing the US and European markets.

What is the future outlook for the Norovirus Nucleic Acid Test Kit market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand and growth.

Norovirus Nucleic Acid Test Kit Market Growing at CAGR — 2026 Report

Norovirus Nucleic Acid Test Kit by Application (Hospital, Clinic), by Types (Dry PCR, Fluorescence PCR), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Norovirus Nucleic Acid Test Kit Market Size | CAGR 10.2 Forecast 2033

Norovirus Nucleic Acid Test Kit Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 77

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Norovirus Nucleic Acid Test Kit Market Overview

The Norovirus Nucleic Acid Test Kit market refers to the industry that provides diagnostic solutions for detecting norovirus infections. As a crucial segment of the in vitro diagnostics market, the Norovirus Nucleic Acid Test Kit market size is estimated to be around $542 million in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2026 to 2033. This industry expansion is driven by increasing demand for accurate and rapid diagnostic tests, advancements in molecular diagnostics, and rising awareness about norovirus infections. The scope of this market encompasses various types of nucleic acid test kits, including PCR-based, isothermal amplification-based, and microarray-based tests, which are used in hospitals, laboratories, and research institutions.

Loading chart…

The Norovirus Nucleic Acid Test Kit market is shaped by several key forces, including technology shifts towards more sensitive and specific diagnostic tests, regulations such as those related to food safety and healthcare, and consumer behavior driven by increasing awareness about norovirus infections. The largest region in this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing demand for diagnostic tests in countries such as China and India. As the market continues to evolve, it is essential for manufacturers and stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Geneodx; Liferiver; Mole; Bioperfectus; BioGerm; Abbott; Kinghawk; BGI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Norovirus Nucleic Acid Test Kit market is experiencing significant growth, driven by various factors. The market dynamics are complex, with multiple elements influencing the Norovirus Nucleic Acid Test Kit market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of norovirus infections is driving the demand for accurate and reliable diagnostic tests, thereby fueling the growth of the Norovirus Nucleic Acid Test Kit market.

Advances in nucleic acid testing technologies have improved the sensitivity and specificity of Norovirus Nucleic Acid Test Kits, making them a preferred choice for diagnosis and contributing to the market's growth forecast.

Restraints2 items

High development costs associated with Norovirus Nucleic Acid Test Kits can limit their adoption in resource-poor settings, thereby restraining the market's growth.

Stringent regulatory requirements for the approval of Norovirus Nucleic Acid Test Kits can hinder the entry of new players into the market and slow down the growth of existing ones.

Opportunities2 items

Emerging economies present significant opportunities for the Norovirus Nucleic Acid Test Kit market, as these countries are investing heavily in their healthcare infrastructure and diagnostic capabilities.

The growing demand for point-of-care testing solutions is expected to drive the adoption of Norovirus Nucleic Acid Test Kits, particularly in outpatient settings and remote areas.

Challenges2 items

Intense competition among existing players in the Norovirus Nucleic Acid Test Kit market can lead to pricing pressures and reduced profit margins, making it challenging for companies to sustain their growth.

The global supply chain for Norovirus Nucleic Acid Test Kits can be disrupted by factors such as raw material shortages, manufacturing delays, and logistics issues, affecting the market's growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Norovirus Nucleic Acid Test Kit market refers to the various uses of these kits in different settings. This segment includes clinical and research applications. Clinical applications account for a significant share of the market, as these kits are widely used in hospitals, laboratories, and clinics to diagnose norovirus infections. The research application segment is also growing, driven by the increasing need for accurate and rapid diagnosis of norovirus in research settings. The Norovirus Nucleic Acid Test Kit segmentation by application is a crucial aspect of market taxonomy, as it helps in understanding the demand for these kits in different end-use sectors.

The Types segment of the Norovirus Nucleic Acid Test Kit market includes different subtypes of test kits, such as real-time PCR and RT-PCR kits. Real-time PCR kits are widely used due to their high sensitivity and specificity, while RT-PCR kits are also popular due to their rapid turnaround time. The types segment is an essential part of the market taxonomy, as it helps in understanding the different technologies used in norovirus nucleic acid testing. The market size of each subtype varies based on factors such as accuracy, cost, and ease of use. Understanding the types segment is crucial for manufacturers to develop and market products that cater to the specific needs of end-users.

Norovirus Nucleic Acid Test Kit Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Dry PCR

Fluorescence PCR

Regional Insights

Loading chart…

The Norovirus Nucleic Acid Test Kit market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of nucleic acid testing, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - high ecosystem maturity, established infrastructure, and increasing demographics; Europe - stringent policies, rising adoption, and growing investments; Asia Pacific - expanding infrastructure, favorable policies, and large demographics; Latin America - growing adoption, increasing investments, and improving infrastructure; Middle East & Africa - rising adoption, expanding infrastructure, and favorable policies.

The regional forecast indicates a significant Norovirus Nucleic Acid Test Kit market growth in Asia Pacific, driven by the increasing demand for nucleic acid testing. The regional forecast also suggests that North America will maintain its position as the largest region, while Europe will experience steady growth due to its established ecosystem maturity and favorable policies.

Competitive Landscape

The Norovirus Nucleic Acid Test Kit market is moderately consolidated, with a mix of global players and local companies competing for market share. The Norovirus Nucleic Acid Test Kit competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are concentrating on regional expansion and localization.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing different strategies to stay ahead in the market:

Geneodx: regional expansion

Liferiver: premium pricing

Mole: OEM tie-ups

Bioperfectus: innovation pipeline

BioGerm: local manufacturing

Abbott: vertical integration

Key Norovirus Nucleic Acid Test Kit Companies8 items

Geneodx

Liferiver

Mole

Bioperfectus

BioGerm

Abbott

Kinghawk

BGI

Market Ecosystem

The Norovirus Nucleic Acid Test Kit ecosystem encompasses a complex network of participants, from upstream technology providers to downstream end users. The ecosystem can be broadly segmented into three main stages: upstream, midstream, and downstream. Upstream participants, such as raw material suppliers and technology providers, create the foundational components of the test kits. Midstream participants, including OEMs/manufacturers and system integrators, assemble and integrate these components into finished products. Downstream participants, comprising distributors, service providers, and end users, facilitate the delivery and utilization of the test kits, ultimately capturing value for the ecosystem as a whole.

Raw material/component suppliers — provide critical reagents and materials

OEMs / manufacturers — design and assemble test kits

Technology providers — develop underlying nucleic acid testing technologies

System integrators / EPCs — integrate test kits into larger diagnostic systems

Distributors / channel partners — facilitate test kit delivery to end users

Regulators/standards bodies — establish and enforce testing and safety standards

End users / buyers — utilize test kits for norovirus detection and diagnosis

In the Norovirus Nucleic Acid Test Kit ecosystem, control points are primarily held by regulators and standards bodies, as their approvals and guidelines influence the adoption of specific test kits. Dependency risks arise from input constraints, such as the availability of certain reagents, and standards compliance. Switching costs and interoperability requirements can also impact the ecosystem, as end users may be limited in their ability to switch between different test kits or integrate them with existing diagnostic systems. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Norovirus Nucleic Acid Test Kit ecosystem through value chain analysis.

Recent Industry Insights

The Norovirus Nucleic Acid Test Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of product portfolios and enhanced distribution networks. Notable mergers and acquisitions have also resulted in increased consolidation and competitiveness within the market. Furthermore, several product and technology launches have improved the sensitivity and specificity of Norovirus Nucleic Acid Test Kits, driving growth in the industry.

Additionally, regulatory changes have led to increased adoption of Norovirus Nucleic Acid Test Kits in various settings, including clinical and research laboratories. A shift in consumer and enterprise trends towards preventive healthcare has also fueled demand for these kits. Funding rounds and expansions have enabled companies to invest in research and development, leading to innovative solutions and improved testing capabilities, ultimately shaping the future of the Norovirus Nucleic Acid Test Kit industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Norovirus Nucleic Acid Test Kit market. The market attractiveness of this sector is significant due to the increasing demand for rapid and accurate diagnostic tests. The competitive intensity is moderate, with several key players vying for market share. Looking at the long-term Norovirus Nucleic Acid Test Kit market outlook, I anticipate steady growth driven by advancements in technology and rising awareness about norovirus infections.

The innovation landscape is characterized by ongoing research into more sensitive and user-friendly test kits. The demand–supply balance is expected to remain stable, with manufacturers ramping up production to meet growing demand. However, key risk factors include regulatory changes and the potential for market saturation. Overall, decision-makers should be aware of these factors to navigate the Norovirus Nucleic Acid Test Kit market effectively.

11 items

1. Executive Summary

2. Norovirus Nucleic Acid Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Norovirus Nucleic Acid Test Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Norovirus Nucleic Acid Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.2. Global Norovirus Nucleic Acid Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Dry PCR

6.2.2. Fluorescence PCR

6.3. Global Norovirus Nucleic Acid Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Norovirus Nucleic Acid Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Norovirus Nucleic Acid Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Norovirus Nucleic Acid Test Kit Market Competition by Key Manufacturers

8.1. Global Norovirus Nucleic Acid Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Norovirus Nucleic Acid Test Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Geneodx

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Liferiver

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mole

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bioperfectus

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BioGerm

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Kinghawk

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BGI

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Norovirus Nucleic Acid Test Kit Market

Figure 4: Global Norovirus Nucleic Acid Test Kit Market: Drivers

Figure 5: Global Norovirus Nucleic Acid Test Kit Market: Challenges

Figure 6: Global Norovirus Nucleic Acid Test Kit Market: Trends

Figure 7: Global Norovirus Nucleic Acid Test Kit Market: Opportunity

Figure 8: Global Norovirus Nucleic Acid Test Kit Market: Restraint

Figure 9: Global Norovirus Nucleic Acid Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Norovirus Nucleic Acid Test Kit Market Value (USD Million) By Region

Figure 15: Global Norovirus Nucleic Acid Test Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Norovirus Nucleic Acid Test Kit Market Value (USD Million) By Region

Figure 23: Global Norovirus Nucleic Acid Test Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Norovirus Nucleic Acid Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Norovirus Nucleic Acid Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Norovirus Nucleic Acid Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Norovirus Nucleic Acid Test Kit Market Value (USD Million) By Region

Table 10: Global Norovirus Nucleic Acid Test Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Norovirus Nucleic Acid Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Norovirus Nucleic Acid Test Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Norovirus Nucleic Acid Test Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Geneodx Basic Information And Sales Area

Table 31: Geneodx. Products Portfolio

Table 32: Liferiver Basic Information And Sales Area

Table 33: Liferiver. Products Portfolio

Table 34: Mole Basic Information And Sales Area

Table 35: Mole. Products Portfolio

Table 36: Bioperfectus Basic Information And Sales Area

Table 37: Bioperfectus. Products Portfolio

Table 38: BioGerm Basic Information And Sales Area

Table 39: BioGerm. Products Portfolio

Table 40: Abbott Basic Information And Sales Area

Table 41: Abbott. Products Portfolio

Table 42: Kinghawk Basic Information And Sales Area

Table 43: Kinghawk. Products Portfolio

Table 44: BGI Basic Information And Sales Area

Table 45: BGI. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Norovirus Nucleic Acid Test Kit Market Value (USD Million) By Region

Table 51: Global Norovirus Nucleic Acid Test Kit Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Norovirus Nucleic Acid Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Geneodx; Liferiver; Mole; Bioperfectus; BioGerm; Abbott; Kinghawk; BGI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options